Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 182 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 3.1.1.23Display the word mapDisplay the reaction diagram Show all sequences 3.1.1.23Colitis 25912803 The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats. causal interaction
therapeutic application
unassigned
4
4
0
Show all pathways known for 3.1.1.23Display the word mapDisplay the reaction diagram Show all sequences 3.1.1.23Colitis 28079617 Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review. causal interaction
therapeutic application
unassigned
4
1
0
Show all pathways known for 3.1.1.23Display the word mapDisplay the reaction diagram Show all sequences 3.1.1.23Endometrial Neoplasms 31357249 Effect of monoacylglycerol lipase on the tumor growth in endometrial cancer. causal interaction
ongoing research
unassigned
3
3
0
Show all pathways known for 3.1.1.23Display the word mapDisplay the reaction diagram Show all sequences 3.1.1.23Glaucoma 30446439 Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment. causal interaction
therapeutic application
unassigned
3
4
0
Show all pathways known for 3.1.1.23Display the word mapDisplay the reaction diagram Show all sequences 3.1.1.23Neoplasms 24676249 Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. causal interaction
therapeutic application
unassigned
3
3
0
Show all pathways known for 3.1.1.23Display the word mapDisplay the reaction diagram Show all sequences 3.1.1.23Neoplasms 27809504 Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors. causal interaction
therapeutic application
unassigned
3
4
0
Show all pathways known for 3.1.1.23Display the word mapDisplay the reaction diagram Show all sequences 3.1.1.23Neoplasms 29962341 Development of thiazole-5-carboxylate derivatives as selective inhibition of monoacylglycerol lipase as a target in Cancer. causal interaction
therapeutic application
unassigned
3
4
0
Show all pathways known for 3.1.1.23Display the word mapDisplay the reaction diagram Show all sequences 3.1.1.23Neoplasms 30696302 Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors. causal interaction
therapeutic application
unassigned
3
4
0
Show all pathways known for 3.1.1.23Display the word mapDisplay the reaction diagram Show all sequences 3.1.1.23Neoplasms 32322464 Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders. causal interaction
unassigned
3
0
Show all pathways known for 3.1.1.23Display the word mapDisplay the reaction diagram Show all sequences 3.1.1.23Neurodegenerative Diseases 30354159 Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders. causal interaction
therapeutic application
unassigned
3
1
0
Results 1 - 10 of 182 > >>